Filter
581 - 590 of 1258 results
Results for
Spotlight On: Protecting Children and Promoting Healthy Families
Spotlight On
Reducing infant mortality. Supporting child welfare agencies. Preventing abuse and neglect. Abt’s work helps support the backbone of policies and programs that protect those who are most vulnerable.
Spotlight On: HIV/AIDS
Spotlight On
Abt Global strengthens HIV/AIDS prevention strategies and expands treatment availability worldwide. We help host country governments advance their health priorities.
Playing the Long Game: Strengthening the Private Health Sector in Ethiopia
Impact Brief
Over 15 years, Abt has led successive USAID projects that have helped strengthen Ethiopia’s private health sector.
Targeting Higher Skills and Healthcare Jobs: How HPOG Grantees Set and Use Performance
Publication
Can mobile phone messages to drug sellers improve treatment of childhood diarrhoea?--A randomized controlled trial in Ghana
Publication
In Southeast Asia, Private Capital Unlocks Small Business Growth
Impact Brief
Through the Australia-supported Investing in Women initiative, Abt connected private capital with high-potential small and medium enterprises, strengthening access to finance and building more resilient labor markets across the region.
Combatting Neglected Tropical Diseases (NTDs)
Project
Ascend Lot 1 – The UK Government’s Foreign, Commonwealth and Development Office (FCDO) set out to invest £100 million in 11 countries in East and Southern Africa and South Asia to advance the impact and sustainability of national programmes tackling NTDs…
Evaluation of the Cascades Job Corps College and Career Academy Pilot: Technical Appendix
Publication
This technical appendix describes the practices, data, and methods used in the Evaluation of the Cascades Job Corps College and Career Academy Pilot.
How Can We Eradicate Infectious Diseases Using Machine Learning?
Podcast
In this month’s episode, Abt experts Jill Berkowitz and Sung-Woo Cho discuss how machine learning can amplify our work combatting malaria—25 million people protected to date—by applying what we’ve learned to other infectious diseases.